(Circulation. 2000;101:221.)
© 2000 American Heart Association, Inc.
Editorials |
From the Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass.
Correspondence to Joseph Loscalzo, MD, PhD, Boston University School of Medicine, Whitaker Cardiovascular Institute, 715 Albany St, W507, Boston, MA 02118. E-mail jloscalz@bu.edu
Key Words: Editorials veins revascularization atherosclerosis grafting
The pioneering work of Favaloro1 established the era of surgical revascularization for the treatment of ischemic heart disease. The benefits of this procedure were recognized early, and the use of the saphenous vein as a bypass conduit rapidly gained widespread acceptance as an effective treatment for angina. However, surgical revascularization has significant shortcomings, principal among which is the high rate of accelerated atherosclerosis that develops in vein grafts: at 10 years after surgery, 40% of grafts are occluded and only 50% are free of significant disease.2
Vein graft failure is a consequence of three related processes. Early after implantation, thrombosis plays a critical role, both by predisposing to acute occlusion and by serving as a stimulus for neointima formation and, ultimately, graft atherosclerosis. Within 6 weeks after implantation, virtually all arterialized vein grafts develop intimal hyperplasia, which, although it only modestly compromises the lumen of the graft, renders the graft susceptible to atherosclerosis.3 The cellular events that account for this intimal response include migration and proliferation of vascular smooth muscle cells, perhaps derived from adventitial fibroblasts (myofibroblasts),4 followed by extracellular matrix synthesis and deposition. This latter process ultimately leads to progressive intimal fibrosis with relatively reduced intimal cellularity.5
Vein grafts are susceptible to intimal hyperplasia and
atherosclerosis for two main reasons. First, explanted
vein grafts are prone to vessel wall ischemia owing to a loss
of functional vasa vasorum; regrowth of these nutrient vessels appears
as early as 5 days after graft placement, but a rich network sufficient
to provide
This article has been cited by other articles:
![]() |
S. Misra, A. A. Fu, A. Puggioni, K. M. Karimi, J. N. Mandrekar, J. F. Glockner, L. A. Juncos, B. Anwer, A. M. McGuire, and D. Mukhopadhyay Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2219 - H2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayranpaa, J. Simpanen, M. W. Hess, K. Werkkala, and P. T. Kovanen Arterial endothelial denudation by intraluminal use of papaverine-NaCl solution in coronary bypass surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 560 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Nath, S. K. R. Kanakiriya, J. P. Grande, A. J. Croatt, and Z. S. Katusic Increased Venous Proinflammatory Gene Expression and Intimal Hyperplasia in an Aorto-Caval Fistula Model in the Rat Am. J. Pathol., June 1, 2003; 162(6): 2079 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Giesler, U. Baum, D. Ropers, S. Ulzheimer, E. Wenkel, M. Mennicke, W. Bautz, W. A. Kalender, W. G. Daniel, and S. Achenbach Noninvasive Visualization of Coronary Arteries Using Contrast-Enhanced Multidetector CT: Influence of Heart Rate on Image Quality and Stenosis Detection Am. J. Roentgenol., October 1, 2002; 179(4): 911 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hong, C. R. Becker, A. Huber, U. J. Schoepf, B. Ohnesorge, A. Knez, R. Bruning, and M. F. Reiser ECG-gated Reconstructed Multi-Detector Row CT Coronary Angiography: Effect of Varying Trigger Delay on Image Quality Radiology, September 1, 2001; 220(3): 712 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz Gene Therapy for Cardiovascular Disease Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 289 - 300. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |